Related Experiment Video
Updated: Jan 21, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Dynamic regulatory features of the protein tyrosine kinases
Neha Amatya1, David Yin-Wei Lin1, Amy H Andreotti2
1Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011, U.S.A.
Abstract:
The SRC, Abelson murine leukemia viral oncogene homolog 1, TEC and C-terminal SRC Kinase families of non-receptor tyrosine kinases (collectively the Src module kinases) mediate an array of cellular signaling processes and are therapeutic targets in many disease states. Crystal structures of Src modules kinases provide valuable insights into the regulatory mechanisms that control activation and generate a framework from which drug discovery can advance. The conformational ensembles visited by these multidomain kinases in solution are also key features of the regulatory machinery controlling catalytic activity. Measurement of dynamic motions within kinases substantially augments information derived from crystal structures. In this review, we focus on a body of work that has transformed our understanding of non-receptor tyrosine kinase regulation from a static view to one that incorporates how fluctuations in conformational ensembles and dynamic motions influence activation status. Regulatory dynamic networks are often shared across and between kinase families while specific dynamic behavior distinguishes unique regulatory mechanisms for select kinases. Moreover, intrinsically dynamic regions of kinases likely play important regulatory roles that have only been partially explored. Since there is clear precedence that kinase inhibitors can exploit specific dynamic features, continued efforts to define conformational ensembles and dynamic allostery will be key to combating drug resistance and devising alternate treatments for kinase-associated diseases.
Insights
Understanding non-receptor tyrosine kinase (Src module kinases) regulation requires dynamic motion insights. Dynamic networks and specific behaviors influence kinase activation, crucial for developing targeted therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Non-receptor tyrosine kinases, including SRC, TEC, and C-terminal SRC Kinase families, are critical in cellular signaling and disease.
- Crystal structures offer static insights, but dynamic motions are key to kinase regulation and activation.
Purpose of the Study:
- To review how dynamic motions and conformational ensembles of non-receptor tyrosine kinases influence their activation.
- To highlight the importance of dynamic regulation in kinase function and drug discovery.
Main Methods:
- Review of existing literature focusing on structural and dynamic studies of Src module kinases.
- Analysis of how conformational ensembles and dynamic motions affect kinase activity.
Main Results:
- Kinase regulation is better understood through dynamic motions, not just static structures.
- Shared regulatory dynamic networks exist across kinase families, with unique dynamics for specific kinases.
- Intrinsically dynamic regions play significant, yet underexplored, regulatory roles.
Conclusions:
- Understanding kinase dynamics is essential for advancing drug discovery and combating resistance.
- Defining conformational ensembles and dynamic allostery will be key for future kinase-targeted therapies.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
05:00Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
Published on: August 9, 2024
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Receptor Tyrosine Kinases
Cis-regulatory Sequences
Cis-regulatory Sequences
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...